chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: vaccines do not prevent getting covid; vaccines do not prevent getting covid; This is a spontaneous report received from a non-contactable reporter (Consumer), Program ID: The reporter is the patient.  An adult female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "vaccines do not prevent getting covid".  Additional information; I have been vaccinated and boosted even though these vaccines do not prevent getting covid I have had it 2 times both after being fully vaccinated.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: PNC20
Symptoms: Poor quality product administered, Syringe issue
Clinical narrative: After injection I removed the syringe from patient's arm/the neck of the syringe broke; the neck of the syringe broke; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from product quality group.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 12Apr2023 as dose number unknown, single (Batch/Lot number: unknown), in arm for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: POOR QUALITY PRODUCT ADMINISTERED (non-serious) with onset 12Apr2023, described as "After injection I removed the syringe from patient's arm/the neck of the syringe broke"; SYRINGE ISSUE (non-serious) with onset 12Apr2023, described as "the neck of the syringe broke".  Additional information: The patient was given Prevnar 20. After injection and removed the syringe from patient's arm, the reporter went to close the safety lock on the needle and the neck of the syringe broke.   The reporter considered "after injection i removed the syringe from patient's arm/the neck of the syringe broke" and "the neck of the syringe broke" associated to pneumococcal 20-val conj vac (dipht CRM197 protein).  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive twice; tested positive twice; This is a spontaneous report received from a non-contactable reporter (Consumer or other non-HCP), Program ID: A 5-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive twice". A caller calling for her grandson about getting a letter saying that the Pfizer Covid-19 Vaccine doesn't stop transmission and doesn't stop from getting Covid because his 5 years old grandson tested positive twice. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: tested positive twice; positive, notes: tested positive twice.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 1.33
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: child received an expired DAPTACEL and ACT-HIB-DILUENT ,with no reported adverse event; Initial information received on 05-Apr-2023 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves a 16 months old male patient, child received an expired DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and HAEMOPHILUS TYPE B (HIB) VACCINE diluent, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation.  On 04-Apr-2023, the patient received dose 4 at 0.5ml total of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE Suspension for injection (strength: standard, route: unknown) (lot number: C5828AA, expiry date: 30-Mar-2023) in the left thigh for Immunization and the patient received suspect HAEMOPHILUS TYPE B (HIB) VACCINE produced by unknown manufacturer (strength, formulation, route, dose, expiry date, lot number: not reported) in unknown administration site for Prophylactic vaccination (Immunisation) and on the same day child received an expired daptacel and act-hib-diluent ,with no reported adverse event (expired product administered).  It was reported, Caller is wanting to know what to do.    Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (DAPTACEL) and HAEMOPHILUS TYPE B (HIB) VACCINE (HAEMOPHILUS TYPE B (HIB) VACCINE) was not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: F
Vaccine: TDAP
Symptoms: Medication error, No adverse event, Wrong product administered
Clinical narrative: ADACEL was given to a 12 month-old. Caller thought they were giving the DTAP but Adacel was incorrectly administered with no reported adverse event; Initial information was received on 12-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 1 years old female patient who experienced adacel was given to a 12 month-old. caller thought they were giving the dtap but adacel was incorrectly administered with no reported adverse event while receiving vaccine diphtheria-2/tetanus/5 ac pertussis vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13); measles vaccine LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), rubella vaccine LIVE (WISTAR RA 27/3), VARICELLA zoster vaccine live (OKA/MERCK) (Proquad); hepatitis a vaccine INACT (Havrix); and HIB VACCINE CONJ (TET TOX) (Acthib).  On 12-Apr-2023, the patient received a dose of suspect diphtheria-2/tetanus/5 ac pertussis vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE lot C6003BA, 01-Jun-2024 via intramuscular route in the left thigh for Immunization.  On 12-Apr-2023 the patient developed a non-serious event of adacel was given to a 12 month-old. caller thought they were giving the dtap but adacel was incorrectly administered with no reported adverse event (wrong product administered) same day following the administration of diphtheria-2/tetanus/5 ac pertussis vaccine.  Action taken with DIPHTHERIA, TETANUS and acellular pertussis vaccine (Adacel) was not applicable.   At time of reporting, the outcome was Unknown for the event adacel was given to a 12 month-old. caller thought they were giving the dtap but adacel was incorrectly administered with no reported adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: IPV
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: One dose of Ipol administered after the excursions of temperature was -2C with no adverse event; One dose of Ipol administered after the excursions of temperature was -2C with no adverse event; Initial information received on 13-Apr-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who "administered one dose of IPV (VERO) [IPOL] after the excursions of temperature was -2c with no adverse event".  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect IPV (VERO), suspension for injection (lot number, expiry date: not reported) via unknown route in unknown administration site (strength: not reported) for prophylactic vaccination (immunization).  On an unknown date the patient "administered one dose of ipol after the excursions of temperature was -2c with no adverse event" (poor quality product administered) (latency: same day) and (product storage error) (latency: unknown).  It was reported, "caller states that the units have been bad for months at a time and she is sure some of the vials has been used. Temperature was -2C. One dose of Ipol, four doses of Typhim, twenty-eight doses of Acthib and nine doses of Tubersol have been administered after the excursions."   Action taken with POLIOMYELITIS VACCINE (INACTIVATED) was not applicable.  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Thrombosis
Clinical narrative: Blood clots / DVT (Deep Vein Thrombosis)
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient was given Moderna bivalent vaccine 24 hours after the use by expiration date. Patient without symptoms. MD was notified. Manufacturer was notified to determine stability of vaccine and adequacy of coverage against COVID.
Age: 14.0
Sex: M
Vaccine: FLU4
Symptoms: Syncope
Clinical narrative: Within less than one minute of receiving the influenza vaccine, the patient had a snycopal episode in which he went limp on the exam table. Woke up within a few seconds. His vital signs were taken and his blood pressure and heart rate were normal. He recovered to his baseline within 1-2 minutes, and was then observed for 30 minutes after, and given orange juice and graham crackers.
Sex: M
Vaccine: COVID19, HPV9
Symptoms: Product storage error
Clinical narrative: after it was out past room temperature past the 12 hour mark and it was actually at 73 to 76 degrees for approximately 31 hours/There was HPV vaccine given to him also on 04Apr2023; This spontaneous report was received from Registered Nurse via Pfizer, referring to a 20-year-old male patient. The patient's historical vaccines included first and second doses of Pfizer covid vaccine. Information regarding the patient's concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not provided.  On 04-APR-2023, the patient started therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered in the right arm as prophylaxis (dose, route of administration, and vaccination scheme frequency were not reported; lot number W011455 has been verified to be a valid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) prefilled syringe, expiration date reported and upon internal validation established as 11-DEC-2024); and tozinameran (PFIZER BIONTECH COVID-19 VACCINE) (reported as Pfizer Bivalent covid vaccine for adults 12 and up), at a dose of 0.3ml given intramuscular to the left arm, as prophylaxis requested for the patient (strength and formulation were not reported; lot number reported as GL1990 and expiration date were not reported). According to the reporter, they had a vaccine administered after it was out past room temperature past the 12 hour mark and it was actually at 73 to 76 degrees for approximately 31 hours and she wanted to confirm the integrity to inquire if the patient needed to be vaccinated (it was unclear if hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) experienced a temperature excursion) (product storage error).
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: On 4/18/2023, 18 hours after vaccine administration, experienced fever, headache, very bad body aches.   Fever at height was 102.2.  Took 4 hours after tylenol and ibuprofen for fever to abate.  Fever gone by next morning, 4/19/23.
Age: 13.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Dizziness, Fatigue, Hypotension, Lethargy
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Hypotension-Severe, Systemic: Weakness-Mild
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: admitted for weakness
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Hip fracture
Clinical narrative: Fall, hip frx
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea
Clinical narrative: Shortness of breath, admission COPD exacerbation
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Headache, Myalgia, NauseaVomiting,  fatigue site pain redness swelling both doses Narrative:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vomiting
Clinical narrative: Headache, Myalgia, NauseaVomiting,  fatigue site pain redness swelling both doses Narrative:
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: Guillain Barre Syndrome.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac murmur, Dementia, Pulmonary fibrosis, Respiratory failure
Clinical narrative: pulmonary fibrosis, O2 dependent, dementia, heart murmur, respiratory failure,
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: I tested positive for covid on 11/08/2022, I went to the urgent care, and they gave me an infusion.  Experienced a headache and a consistent runny nose. Alos I was experiencing a lot of fatigue and chills throughout the day. They also prescribed Claritin and ibuprofen for some of the symptoms. It took a month for the cough to go away. Just recently I started to feel a little better still experiencing fatigue and a heavy feeling in my legs.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I tested positive for covid on 11/08/2022, I went to the urgent care, and they gave me an infusion.  Experienced a headache and a consistent runny nose. Alos I was experiencing a lot of fatigue and chills throughout the day. They also prescribed Claritin and ibuprofen for some of the symptoms. It took a month for the cough to go away. Just recently I started to feel a little better still experiencing fatigue and a heavy feeling in my legs.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Pyrexia
Clinical narrative: I experienced mild fever and coughing
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: HOSPITALIZATION
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: PATIENT RECEIVED FROM OUTSIDE SOURCE  HYPOTENSION
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Arthralgia, Dyskinesia, Headache, Lymph node pain, Lymphadenopathy
Clinical narrative: Morning of 4/14/23 woke up with bad headache and fever, swelling and soreness of left shoulder and axillary lymph nodes. Around 10:30a would have upper body twitching every few seconds to every 30 seconds. Head and neck and upper body would flex forward like a myoclonic contraction. Motrin helped with pain but not the twitching. Went to a stand alone ER for evaluation afternoon of 4/14/23. Was given Valium 5 mg that stopped the movement. Twitching would return about 8 hours after dose but would resolve with Valium being given again. Last dose of Valium was on 4/15/23 at 3:15pm. No twitching after that. Arm swelling and lymph node swelling has resolved as well.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Muscle twitching, Pyrexia, Swelling
Clinical narrative: Morning of 4/14/23 woke up with bad headache and fever, swelling and soreness of left shoulder and axillary lymph nodes. Around 10:30a would have upper body twitching every few seconds to every 30 seconds. Head and neck and upper body would flex forward like a myoclonic contraction. Motrin helped with pain but not the twitching. Went to a stand alone ER for evaluation afternoon of 4/14/23. Was given Valium 5 mg that stopped the movement. Twitching would return about 8 hours after dose but would resolve with Valium being given again. Last dose of Valium was on 4/15/23 at 3:15pm. No twitching after that. Arm swelling and lymph node swelling has resolved as well.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Erythema, Pruritus, Skin warm
Clinical narrative: Redness covering almost all of the upper right arm. Warm to the touch and itchy.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Acute respiratory failure, COVID-19, Cardiac arrest, Death
Clinical narrative: On 4/10/2023, patient presented to the emergency department at local Community Hospital for shortness of breath. Patient had had onset of COVID-like symptoms on 4/9/2023; She was given a COVID-19 NAA test, and it resulted positive. While receiving care in the emergency room, patient's condition deteriorated; Her EKG indicated ST-Segment Elevation Myocardial Infarction, so she was transferred via ambulance to alternate Hospital for additional treatment. During the transfer, patient had respiratory arrest and lost pulses, so chest compressions were started by EMS. Further resuscitation efforts were made upon arrival to in the emergency department at Hospital. Patient's condition did not improve, and she died on 4/11/2023 in the hospital emergency department. Her primary diagnosis was Cardiac Arrest with additional diagnoses of COVID-19 and Acute hypoxemic respiratory failure due to COVID-19.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the hospital emergency departments.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Electrocardiogram abnormal, General physical health deterioration, Malaise, Pulse absent
Clinical narrative: On 4/10/2023, patient presented to the emergency department at local Community Hospital for shortness of breath. Patient had had onset of COVID-like symptoms on 4/9/2023; She was given a COVID-19 NAA test, and it resulted positive. While receiving care in the emergency room, patient's condition deteriorated; Her EKG indicated ST-Segment Elevation Myocardial Infarction, so she was transferred via ambulance to alternate Hospital for additional treatment. During the transfer, patient had respiratory arrest and lost pulses, so chest compressions were started by EMS. Further resuscitation efforts were made upon arrival to in the emergency department at Hospital. Patient's condition did not improve, and she died on 4/11/2023 in the hospital emergency department. Her primary diagnosis was Cardiac Arrest with additional diagnoses of COVID-19 and Acute hypoxemic respiratory failure due to COVID-19.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the hospital emergency departments.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory arrest, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: On 4/10/2023, patient presented to the emergency department at local Community Hospital for shortness of breath. Patient had had onset of COVID-like symptoms on 4/9/2023; She was given a COVID-19 NAA test, and it resulted positive. While receiving care in the emergency room, patient's condition deteriorated; Her EKG indicated ST-Segment Elevation Myocardial Infarction, so she was transferred via ambulance to alternate Hospital for additional treatment. During the transfer, patient had respiratory arrest and lost pulses, so chest compressions were started by EMS. Further resuscitation efforts were made upon arrival to in the emergency department at Hospital. Patient's condition did not improve, and she died on 4/11/2023 in the hospital emergency department. Her primary diagnosis was Cardiac Arrest with additional diagnoses of COVID-19 and Acute hypoxemic respiratory failure due to COVID-19.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the hospital emergency departments.
Age: 42.0
Sex: F
Vaccine: YF
Symptoms: Discomfort, Incorrect route of product administration
Clinical narrative: Vaccine administered via Intramuscular route in error at 3:20.  The correct administration is Subcutaneous.  Patient observed for 30 minutes.  Vaccine tolerated well.   Pt advised to hydrate and take tylenol or Ibuprofen for discomfort
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal discolouration, Oropharyngeal pain, Pharyngitis streptococcal, Pyrexia
Clinical narrative: I woke up with a really sore throat and feverish. I took Ibuprofen during the day and didn't get better so I contacted the urgent care center and they recommended a telehealth visit so I did that. They prescribed an antibiotic for strep throat. I looked at my throat and I had white patches.  The symptoms lasted 3 to 4 days.
Age: 70.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Body temperature increased, Dyspnoea, Fatigue, Headache, Influenza like illness
Clinical narrative: I developed flulike symptoms. I had headaches, sinus drainage, had low grade temperature, high as 102 degrees and felt bad body aches. My symptoms lasted seven days.  I still have some long term symptoms today.  My long term symptoms are shortness of breath and fatigue.
Age: 70.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Pain, Paranasal sinus hypersecretion
Clinical narrative: I developed flulike symptoms. I had headaches, sinus drainage, had low grade temperature, high as 102 degrees and felt bad body aches. My symptoms lasted seven days.  I still have some long term symptoms today.  My long term symptoms are shortness of breath and fatigue.
Age: 66.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Cough, Influenza virus test negative, Nasopharyngitis, Pyrexia, Respiratory syncytial virus test negative
Clinical narrative: 2/23/23 I felt like I was getting a cold. I had a little tickle in my throat, a mild cough and a little congested. Over the next week, it became worse. My cough and congestion were worse. I had 101.5 to 102 fever. I did four at home COVID tests that were all negative.  On 3/4/23 I went to Urgent Care because of my fever.  I was tested for RSV, Flu and COVID and all were negative.  I got a prescription for an antibiotic because they felt like I had pneumonia in one lung.  A side effect for this antibiotic was ruptured tendons. After two or three doses, I woke up early in the morning with a pain in the back of my ankle. I stopped taking the medication. I went back to the Urgent Care and told them I would not take the antibiotic anymore. My lungs sounded clear, the fever was gone, but I still had some cold symptoms that were improving. By March 11,2023, I felt well.
Age: 66.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Respiratory tract congestion, SARS-CoV-2 test negative, Throat irritation
Clinical narrative: 2/23/23 I felt like I was getting a cold. I had a little tickle in my throat, a mild cough and a little congested. Over the next week, it became worse. My cough and congestion were worse. I had 101.5 to 102 fever. I did four at home COVID tests that were all negative.  On 3/4/23 I went to Urgent Care because of my fever.  I was tested for RSV, Flu and COVID and all were negative.  I got a prescription for an antibiotic because they felt like I had pneumonia in one lung.  A side effect for this antibiotic was ruptured tendons. After two or three doses, I woke up early in the morning with a pain in the back of my ankle. I stopped taking the medication. I went back to the Urgent Care and told them I would not take the antibiotic anymore. My lungs sounded clear, the fever was gone, but I still had some cold symptoms that were improving. By March 11,2023, I felt well.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, UNSPECIFIED
Age: 0.5
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: MA administered Hib vaccine instead of Flu vaccine which was ordered by doctor. Patient will have to received additional dose of Hib vaccine at 15 month physical. Parent contacted and no adverse reaction reported by parent at the time.
Age: 15.0
Sex: M
Vaccine: YF
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: Administered Yellow Fever vaccine via Intramuscular route in error.  Correct administration route is subcutaneous. Observed patient for 30 minutes.  Tolerated vaccine well. No adverse affect noted.  Advised to hydrate and take tylenol or ibuprofen for discomfort
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Adrenal mass, Gastrointestinal disorder, Hypothyroidism, Impaired work ability, Laboratory test abnormal
Clinical narrative: Originally, I went to my primary doctor, and I had abdominal issues.  He sent me to the ER and they ran some test and labs.  They found a mass on my adrenal gland.  They gave me some medications for the pain I was experiencing.  I thought it was Appendicitis.  Which it did not end of being that.  About a few days of rest, the abdominal issues subsided.  That was the end of that.  I did go back to my primary to follow-up on the mass.  He sent me to the endocrinologist about the mass.  They are monitoring my labs and my hypothyroidism.  So far it has not changed or worsen.  They have prescribed weight loss medication.  They have also prescribed me Topamax for the migraines that I always have.  Around September I started having more migraines that I have had to miss work more.  I have been seeing a neurologist.  They have changed medications.  I have stopped the Topamax.  I have also done recent labs which show increased levels of cortisol.  I am unsure if it has anything to do with tumor they found.  Then on October 16th I got my 4th COVID shot.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Neoplasm, Pain
Clinical narrative: Originally, I went to my primary doctor, and I had abdominal issues.  He sent me to the ER and they ran some test and labs.  They found a mass on my adrenal gland.  They gave me some medications for the pain I was experiencing.  I thought it was Appendicitis.  Which it did not end of being that.  About a few days of rest, the abdominal issues subsided.  That was the end of that.  I did go back to my primary to follow-up on the mass.  He sent me to the endocrinologist about the mass.  They are monitoring my labs and my hypothyroidism.  So far it has not changed or worsen.  They have prescribed weight loss medication.  They have also prescribed me Topamax for the migraines that I always have.  Around September I started having more migraines that I have had to miss work more.  I have been seeing a neurologist.  They have changed medications.  I have stopped the Topamax.  I have also done recent labs which show increased levels of cortisol.  I am unsure if it has anything to do with tumor they found.  Then on October 16th I got my 4th COVID shot.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Increased viscosity of upper respiratory secretion, Infection, Nasopharyngitis, Pyrexia
Clinical narrative: I had a low-grade fever that, felt miserable, had thick green snot. I thought it was just a head cold that would go away but it persisted and made my sinuses hurt awful. I called my doctor's office, to have a telehealth visit. I described my symptoms; I was prescribed amoxicillin for the infection that I am currently taking the last capsule today.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus pain
Clinical narrative: I had a low-grade fever that, felt miserable, had thick green snot. I thought it was just a head cold that would go away but it persisted and made my sinuses hurt awful. I called my doctor's office, to have a telehealth visit. I described my symptoms; I was prescribed amoxicillin for the infection that I am currently taking the last capsule today.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Feeling abnormal, Headache, Oropharyngeal pain
Clinical narrative: So, on 4/7 I woke up with a sore throat, but I thought it was allergies. The next day I woke up with a sore throat. It progressed into the night. I had a headache, sore throat, congestion, difficulty breathing, aches and pains and a very bad headache. It felt like someone was hitting me with a sledgehammer. I called my local provider, and I had a telehealth visit and they prescribed me with Paxlovid. Sunday night was my first dose. I do feel better, but I don't think I'm over it completely.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: So, on 4/7 I woke up with a sore throat, but I thought it was allergies. The next day I woke up with a sore throat. It progressed into the night. I had a headache, sore throat, congestion, difficulty breathing, aches and pains and a very bad headache. It felt like someone was hitting me with a sledgehammer. I called my local provider, and I had a telehealth visit and they prescribed me with Paxlovid. Sunday night was my first dose. I do feel better, but I don't think I'm over it completely.
Age: 5.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: No adverse event, Underdose
Clinical narrative: Incorrect vaccine given for this age of patient. Received 6mo-4yr covid monovalent dose instead of 5-11yrs covid monovalent dose. No adverse reaction.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Epstein-Barr virus test, Gingival bleeding, HIV test, Hepatitis viral test, Immune thrombocytopenia
Clinical narrative: Patient found to have thrombocytopenia (platelet 16K) on 4/17/2023 with gingival bleeding.  He is being treated acute ITP (today is day 2 of hospitalization) and will be receiving pulse dexamethasone as his platelet count continues to decrease.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Parasite blood test, Platelet count decreased, Thrombocytopenia
Clinical narrative: Patient found to have thrombocytopenia (platelet 16K) on 4/17/2023 with gingival bleeding.  He is being treated acute ITP (today is day 2 of hospitalization) and will be receiving pulse dexamethasone as his platelet count continues to decrease.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Pfizer reviewed the stability of the vaccine you received and determined that it likely did not maintain the activity necessary to protect against COVID-19 at time of administration. Pfizer cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Pfizer reviewed the stability of the vaccine you received and determined that it likely did not maintain the activity necessary to protect against COVID-19 at time of administration. Pfizer cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Coagulopathy, Diabetic vascular disorder, Type 2 diabetes mellitus
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE 5/18/2022 DM 2 W PERIPHERAL VASCULAR DISEASE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/13/2022 DM 2 W PERIPHERAL VASCULAR DISEASE
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 55.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Dizziness, Dizziness postural, Hypersensitivity, Hypoacusis, Ocular discomfort
Clinical narrative: I early February I had pressure behind my eyes, muffled ears. It felt like I was having some sinus drainage issues, yet it didn't feel like a sinus infection. I started experiencing extreme dizzy sensation in my head, it felt as if when I moved my head it would take a moment for brain to move. I went to a local pharmacy and discovered I had vertigo caused by allergies. I was advised by the pharmacist to try ZYRTEC to clear my allergies. Within the hour of taking the ZYRTEC my symptoms were cleared, it did take five days for the vertigo to be completely gone.
Age: 55.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Paranasal sinus hypersecretion, Vertigo
Clinical narrative: I early February I had pressure behind my eyes, muffled ears. It felt like I was having some sinus drainage issues, yet it didn't feel like a sinus infection. I started experiencing extreme dizzy sensation in my head, it felt as if when I moved my head it would take a moment for brain to move. I went to a local pharmacy and discovered I had vertigo caused by allergies. I was advised by the pharmacist to try ZYRTEC to clear my allergies. Within the hour of taking the ZYRTEC my symptoms were cleared, it did take five days for the vertigo to be completely gone.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Diarrhoea, Exposure to SARS-CoV-2, Feeling cold
Clinical narrative: My husband and I were on a trip, and when the trip ended I started with symptoms that was initially diarrhea on Friday, 03/17. My husband tested positive for COVID19 on the 18th and then on Monday the 20th I was cold all day long, couldn't get warm. That evening I started having a post nasal drip. Tuesday morning I did a home test and it was positive. At that point I called Urgent Care and got an appt for that evening. I saw the PA and got a PCR COVID19 test done which came back positive the next morning. I started Paxlovid that night. I had a low grade fever, 100.4. Post nasal drip and a little cough, it was mostly upper respiratory. Better after 24 hours and took all five days of Paxlovid. Finally felt like myself again after about a week total. I also had COVID19 in September of 21 and had to get the Monoclonal Antibodies and it was really bad- this case was nothing like that. Much milder.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory symptom, SARS-CoV-2 test positive, Upper-airway cough syndrome
Clinical narrative: My husband and I were on a trip, and when the trip ended I started with symptoms that was initially diarrhea on Friday, 03/17. My husband tested positive for COVID19 on the 18th and then on Monday the 20th I was cold all day long, couldn't get warm. That evening I started having a post nasal drip. Tuesday morning I did a home test and it was positive. At that point I called Urgent Care and got an appt for that evening. I saw the PA and got a PCR COVID19 test done which came back positive the next morning. I started Paxlovid that night. I had a low grade fever, 100.4. Post nasal drip and a little cough, it was mostly upper respiratory. Better after 24 hours and took all five days of Paxlovid. Finally felt like myself again after about a week total. I also had COVID19 in September of 21 and had to get the Monoclonal Antibodies and it was really bad- this case was nothing like that. Much milder.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic arteriosclerosis, Hypotension, Urinary retention
Clinical narrative: HYPOTENSION 5/28/2021 ATHEROSCLEROSIS OF AORTA  HYPOTENSION 5/28/2021 URINARY RETENTION
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Laboratory test, Loss of consciousness
Clinical narrative: Patient he had a sharp pain in stomach during the night of 4/18/23. His roommate then told him that he passed out for 10-15 seconds. When he awoke, he felt fine and the stomach pain was gone. He said that he did go to the emergency department. They did testing and said that there were no findings of merit. He was told to follow up with primary care physician.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Fatigue
Clinical narrative: It was discovered after the vaccine was administered that it was expired.  The vaccine was labeled with the expiration date 5/17/2023, but when we looked it up online, the expiration date was 3/31/2023.  The patient was observed for 15 minutes and dismissed in stable condition.  We attempted to speak with his mother over the phone the evening of the incident, but she did not answer the phone.  We spoke with her this morning, and she reported that he is doing fine.  His only symptom is fatigue.  He will be evaluated by a doctor tomorrow.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Pathological fracture, Prostate cancer
Clinical narrative: R09.02 HYPOXIA 6/4/2021 LEFT FEMUR PATHOLOGICAL FX, INIT R09.02 HYPOXIA 6/4/2021 ADENOCARCINOMA, PROSTATE R09.02 HYPOXIA 6/4/2021 ADENOCARCINOMA, PROSTATE
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/9/2022 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, SARS-CoV-2 test, SARS-CoV-2 test negative, Secretion discharge
Clinical narrative: Pt had been in inpatient rehab since 4/5 where she tested negative for COVID on admission. Pt was retested for COVID on 4/17 and had complaints of mild shortness of breath and increased secretions. She also had family with COVID.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Diabetic ketoacidosis, Hypertension, Hypotension, Type 2 diabetes mellitus
Clinical narrative: I95.9 HYPOTENSION 10/12/2021 DM 2 W KETOACIDOSIS J96.00 ACUTE RESPIRATORY FAILURE 10/12/2021 DM 2 W KETOACIDOSIS I95.9 HYPOTENSION 10/12/2021 HTN (HYPERTENSION) J96.00 ACUTE RESPIRATORY FAILURE 10/12/2021 HTN (HYPERTENSION)
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Malaise, Nasopharyngitis, SARS-CoV-2 test positive
Clinical narrative: Started feeling ill 4/4/2023.  Moved to feeling like a really bad cold on 4/5/2023.  Communicated via email with my primary care physician on 4/6/2023 and received a prescription for Paxlovid on 4/7/2023.  Started taking the prescription that evening, having stopped taking my Lovastatin and Tamsulosin prescriptitons prior.  By the evening of 4/9/2023 was feeling infinitely better.  Completed the Paxlovid prescription.  Restarting the Lovastatin and Tamsulosin on 4/19/2023.  I don't seem to have any lasting symptoms except a cough, which may also be due to seasonal allergie.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY HYPOTENSION  05/30/22  - patient had same adverse effects again
Age: 35.0
Sex: F
Vaccine: PNC20, TDAP, VARCEL
Symptoms: Product use issue
Clinical narrative: Patient is taking Humira so she should not have received a live vaccine(vericella).  Patient instructed to hold Humira for 3 week if able. Patient is to watch and report to us any signs of chicken pox.